Table 3. Subgroup analysis results.
Studies | Number of patients | R(95%CI) | Heterogeneity test | Effects model | Venice Rating | Overall credibility | |
---|---|---|---|---|---|---|---|
Low latitude | 5 | 415 | -0.26(-0.35,-0.16) | I2 = 16%, P = 0.31 | F | BAA | Moderate evidence |
Middle latitude | 9 | 1834 | -0.11(-0.15,-0.06) | I2 = 38%, P = 0.10 | F | AAA | Strong evidence |
Developed countries | 8 | 1723 | -0.11(-0.16,-0.06) | I2 = 0%, P = 0.47 | R | AAA | Strong evidence |
Developing countries | 6 | 526 | -0.21(-0.36,-0.06) | I2 = 67%,P = 0.01 | R | BCA | Weak evidence |